These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 16269515

  • 1. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF, Tan D, Walker AM, Chen WY.
    Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN, Galsgaard ED, Nielsen JH, Møldrup A.
    Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
    Cataldo L, Chen NY, Yuan Q, Li W, Ramamoorthy P, Wagner TE, Sticca RP, Chen WY.
    Int J Oncol; 2000 Dec; 17(6):1179-85. PubMed ID: 11078803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.
    Bustamante JJ, Grigorian AL, Muñoz J, Aguilar RM, Treviño LR, Martinez AO, Haro LS.
    Growth Horm IGF Res; 2010 Aug; 20(4):298-304. PubMed ID: 20472479
    [Abstract] [Full Text] [Related]

  • 11. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.
    Chang WP, Ye Y, Clevenger CV.
    Mol Cell Biol; 1998 Feb; 18(2):896-905. PubMed ID: 9447986
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
    Zhang Y, Gc S, Patel SB, Liu Y, Paterson AJ, Kappes JC, Jiang J, Frank SJ.
    Mol Cell Endocrinol; 2019 Jul 15; 492():110445. PubMed ID: 31100495
    [Abstract] [Full Text] [Related]

  • 14. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites.
    Kinet S, Bernichtein S, Kelly PA, Martial JA, Goffin V.
    J Biol Chem; 1999 Sep 10; 274(37):26033-43. PubMed ID: 10473550
    [Abstract] [Full Text] [Related]

  • 15. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P, Kaushik G, Ghosh C, Standing D, Ali Sayed AA, Choudhury S, Subramaniam D, Manzardo A, Banerjee T, Santra S, Ramamoorthy P, Butler M, Padhye SB, Baranda J, Kasi A, Sun W, Tawfik O, Coppola D, Malafa M, Umar S, Soares MJ, Saha S, Weir SJ, Dhar A, Jensen RA, Thomas SM, Anant S.
    Gastroenterology; 2020 Apr 10; 158(5):1433-1449.e27. PubMed ID: 31786131
    [Abstract] [Full Text] [Related]

  • 16. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.
    Int J Oncol; 2012 Dec 10; 41(6):2285-95. PubMed ID: 23064471
    [Abstract] [Full Text] [Related]

  • 17. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
    Scotti ML, Langenheim JF, Tomblyn S, Springs AE, Chen WY.
    Breast Cancer Res Treat; 2008 Sep 10; 111(2):241-50. PubMed ID: 17955362
    [Abstract] [Full Text] [Related]

  • 18. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
    Standing D, Dandawate P, Anant S.
    Front Endocrinol (Lausanne); 2022 Sep 10; 13():1112987. PubMed ID: 36714582
    [Abstract] [Full Text] [Related]

  • 19. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA.
    Endocr Rev; 1998 Jun 10; 19(3):225-68. PubMed ID: 9626554
    [Abstract] [Full Text] [Related]

  • 20. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
    Yang N, Langenheim JF, Wang X, Jiang J, Chen WY, Frank SJ.
    Mol Endocrinol; 2008 Apr 10; 22(4):978-88. PubMed ID: 18096690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.